Hence, while pomalidomide is described as pro-apoptotic through caspase-8 upregulation and inhibiting IAP-2 in cancer cell lines (26, 27), in this study, we observed that pomalidomide treatment paradoxically supported cell survival through upregulating Bcl-2, improving the viability of CD4+ T cells. This evidence concerns the gene BIRC2 and cancer.